Introduction
The purchase agreement for a sponsor-owned company sold to a corporate often shows more plainly than the price where the risk ended up. When The Home Depot agreed in March 2024 to buy SRS Distribution from Leonard Green & Partners and Berkshire Partners for about $18.25 billion, the sellers left a $25 million escrow and no representations that outlived the closing, while the buyer promised about $894 million if antitrust law stopped the deal. That asymmetry is the shape of a well-run strategic sale: the corporate pays for what it can do with the business, and the seller's bank, typically its financial sponsors group (FSG) working with mergers and acquisitions (M&A) and industry bankers, turns that willingness into a contract that pays the fund once, in cash, and leaves nothing at risk.
Positioning a Sponsor-Owned Company for Corporate Buyers
How corporate and sponsor bidders compete on price is covered in the account of sponsor bidders facing corporates in an auction. The seller's question is narrower: what must a corporate development team see before its board pays for value that only its own company can create?
The Synergy Case and Who Captures It
Sponsor exit materials are usually written around a standalone forecast of earnings before interest, taxes, depreciation and amortization (EBITDA) and the debt it supports. A corporate needs a second document showing the business inside its own: overlapping branches, shared suppliers, cross-selling.
- Synergy Case
The part of a sell-side presentation that estimates the cost savings and revenue gains a specific strategic buyer could earn by combining the target with its own business. It uses the seller's data in the buyer's terms, so the buyer's team can test and adopt it.
Synergies belong to the buyer until competition, usually a sponsor bid that sets a floor, forces it to share them; the valuation guide's article on who captures synergy value shows how far a buyer could go.
What Corporate Buyers Distrust in a Sponsor-Owned Asset
Corporate buyers know the sponsor model. Four suspicions recur in their diligence, and each becomes a price cut or a demand for protection unless the seller answers it first:
- EBITDA add-backs that a strategic will not count in its own reported results.
- Deferred investment in maintenance, systems or staff that flattered late-hold cash flow.
- Management equity that pays out in full at closing, weakening the reason to stay through integration.
- A capital structure built for leverage, to be repaid or unwound at closing.
The remedies take longer than a sale process: a quality of earnings report reconciling adjusted EBITDA to cash, vendor due diligence of the kind set out in the sponsor exit decision framework, and materials that lead with reported earnings and evidence each adjustment, since marketing a lender's adjusted figure invites a lower bid on a smaller number.
What the Sponsor Wants in the Purchase Agreement
A sponsor sells for a fund that must return cash to its limited partners (LPs) and eventually wind up, so it wants cash at closing, nothing left behind and a firm closing date. Each priority maps to a term the corporate would rather avoid:
| Sponsor priority | Term that delivers it | What the corporate buyer prefers |
|---|---|---|
| All proceeds at closing | All-cash price, small adjustment escrow | Part payment in its shares, or an earn-out |
| No exposure after closing | Representations that expire; warranty and indemnity (W&I) insurance | Seller indemnity backed by a large escrow |
| Certainty of closing | Broad antitrust efforts covenant; reverse termination fee | Limits on the remedies it must accept |
Indemnities, Escrows and W&I Insurance
In a private sale the seller's representations usually carry an indemnity, often backed by an escrow held back from the price. A fund that has distributed its proceeds cannot stand behind that promise for years, so sponsors push for representations that expire at closing, with the buyer relying on insurance.
- Warranty and Indemnity (W&I) Insurance
A policy, called representations and warranties (R&W) insurance in the US, that pays the buyer for losses from breaches of the seller's representations, up to a limit and above a retention. Because the buyer claims against the insurer, the seller keeps little or no indemnity exposure after closing.
Policies exclude known problems and some regulatory exposures, so specific indemnities persist in sectors such as healthcare, as the healthcare guide's treatment of representations and indemnification shows.
Earn-outs and payment in the buyer's stock meet similar resistance: an earn-out leaves the fund holding a claim on a company it no longer controls, as the guide to earn-out structures explains, and stock adds market risk and often a lock-up.
Antitrust Risk and the Reverse Termination Fee
A corporate in the same industry is the buyer most likely to face a lengthy antitrust review. Sponsors negotiate two protections: an efforts covenant obliging the buyer to accept remedies, at its strongest a hell-or-high-water clause requiring whatever divestitures regulators demand, and a reverse termination fee if the deal is blocked or misses its outside date. Sponsor buyers' use of the fee is covered in the article on commitment letters and reverse termination fees.
Buyers that accept either protection usually want something back, in price or in time.
Home Depot and SRS: The Seller's Terms in One Agreement
SRS, a roofing, landscaping and pool supply distributor with more than 760 branches in 47 states, shows how far a seller can carry those priorities. Home Depot planned to pay with cash on hand and new debt, advised by J.P. Morgan, and the merger agreement names Leonard Green, Berkshire Partners and Tenex Capital Management as the sponsors:
| Seller priority | SRS agreement term | Effect for the sponsors |
|---|---|---|
| Cash at closing | Cash price adjusted for debt, cash, expenses and working capital | Proceeds at one closing |
| No exposure after closing | No representation, warranty or pre-closing covenant survives | No indemnity claims |
| Small holdback | Escrow for the closing adjustment | About 0.14% of the price |
| Fast approval | Majority stockholder consent within 24 hours of signing | No vote risk |
| Antitrust certainty | Fee if blocked, or unclosed by the outside date | About 4.9% of the price |
| Time for review | Outside date March 2025, plus six- and three-month antitrust extensions | Up to 21 months |
Home Depot kept protections too: remedies were limited to SRS's own assets, with no divestiture of Home Depot businesses and nothing amounting to a material adverse effect, a capped covenant offset by a large fee. No insurance policy appears in the agreement, so any protection against undisclosed problems was the buyer's own, as for acquirers of public companies.
Dan Tinker stayed as chief executive, and at the closing on June 18, 2024 certain SRS managers reinvested part of their after-tax proceeds in Home Depot shares, some subject to vesting, a common corporate answer to equity that pays out at closing. Home Depot told investors in its announcement that the deal would add to cash earnings per share (EPS) in its first year excluding synergies.
Staffing the Sale and Weighing It Against Other Exits
The FSG coverage banker typically holds the sponsor relationship and keeps the sale aligned with the fund's priorities, the industry group brings the buyer map and standing with corporate development teams, and M&A execution runs the process. With corporates as likely buyers, the industry group or M&A often leads day to day, though platforms divide roles differently, as the coverage triangle behind sponsor deals explains.
A Strategic Sale Against the Other Exits
A strategic sale often brings the highest price and a clean exit, at the cost of time and regulatory exposure. A secondary buyout trades some price for speed and visible financing, as the article on sponsor-to-sponsor deals explains; an initial public offering (IPO) keeps upside but returns cash slowly, covered in the coverage view of sponsor-backed IPOs.
A strategic buyer faces a limit sponsors do not: its chief executive must defend the price to its own shareholders on announcement day, and Home Depot defended SRS with a case that worked before synergies. A seller that gives a corporate a synergy case its board can repeat in public makes a higher price defensible and a clean contract cheap to concede, since a confident buyer expects neither expired representations nor the fee to cost it anything. The terms a sponsor wins on a strategic sale end up measuring how well the asset was explained.
